TERTIARY STRUCTURE DATA |
Homo sapiens
|
NMR structure; catalytic domain; complex with non-peptidic sulfonomide inhibitor |
0.00 Å |
1EUB |
1EUB |
1EUB |
1EUB |
1EUB |
1EUB |
Zhang et al., 2000 |
NMR structure; catalytic domain; complex with inhibitor WAY-151693 |
0.00 Å |
1FLS |
1FLS |
1FLS |
1FLS |
1FLS |
1FLS |
Moy et al., 2000 |
NMR structure; catalytic domain; complex with inhibitor WAY-151693 |
0.00 Å |
1FM1 |
1FM1 |
1FM1 |
1FM1 |
1FM1 |
1FM1 |
Moy et al., 2000 |
C-terminal hemopexin-like domain |
2.70 Å |
1PEX |
1PEX |
1PEX |
1PEX |
1PEX |
1PEX |
Gomis-Ruth et al., 1996 |
theoretical model |
0.00 Å |
1UC1 |
1UC1 |
1UC1 |
1UC1 |
1UC1 |
1UC1 |
|
matrix metalloproteinase-13 complexed with non-zinc binding inhibitor |
1.70 Å |
1XUC |
1XUC |
1XUC |
1XUC |
1XUC |
1XUC |
Engel et al., 2005 |
matrix metalloproteinase-13 complexed with non-zinc binding inhibitor |
1.80 Å |
1XUD |
1XUD |
1XUD |
1XUD |
1XUD |
1XUD |
Wasserman, 2005 |
matrix metalloproteinase-13 complexed with non-zinc binding inhibitor |
1.85 Å |
1XUR |
1XUR |
1XUR |
1XUR |
1XUR |
1XUR |
Wasserman, 2005 |
catalytic domain; complex with pyrimidinetrione inhibitor 5-(2-ethoxyethyl)-5-[4-(4-fluorophenoxy)phenoxy]pyrimidine-2,4,6(1H,3H,5H)-trione |
2.30 Å |
1YOU |
1YOU |
1YOU |
1YOU |
1YOU |
1YOU |
Blagg et al., 2005 |
catalytic domain; complex with WAY-033 |
2.00 Å |
1ZTQ |
1ZTQ |
1ZTQ |
1ZTQ |
1ZTQ |
1ZTQ |
Wu et al., 2005 |
catalytic domain; complex with hydroxamic acid inhibitor SM-25453 |
2.37 Å |
2D1N |
2D1N |
2D1N |
2D1N |
2D1N |
2D1N |
Kohno et al., 2006 |
complex with TIMP-2 |
2.00 Å |
2E2D |
2E2D |
2E2D |
2E2D |
2E2D |
2E2D |
Maskos et al., 2007 |
catalytic domain; complex with benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-C]pyrimidine-2-carboxylate |
1.74 Å |
2OW9 |
2OW9 |
2OW9 |
2OW9 |
2OW9 |
2OW9 |
Johnson et al., 2007 |
mmp13 catalytic domain complexed with 4-[1-methyl-2,4- dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin- 3(2h)-yl]methylbenzoic acid |
2.30 Å |
2OZR |
2OZR |
2OZR |
2OZR |
2OZR |
2OZR |
Johnson et al., 2007 |
catalytic domain; complex with WAY-344 |
2.80 Å |
2PJT |
2PJT |
2PJT |
2PJT |
2PJT |
2PJT |
Huang et al., 2007 |
mature peptidase |
1.70 Å |
2YIG |
2YIG |
2YIG |
2YIG |
2YIG |
2YIG |
De et al., 2011 |
mature peptidase |
1.90 Å |
3ELM |
3ELM |
3ELM |
3ELM |
3ELM |
3ELM |
Monovich et al., 2009 |
mature peptidase |
1.95 Å |
3I7G |
3I7G |
3I7G |
3I7G |
3I7G |
3I7G |
Heim-Riether et al., 2009 |
mature peptidase |
2.21 Å |
3I7I |
3I7I |
3I7I |
3I7I |
3I7I |
3I7I |
Heim-Riether et al., 2009 |
mature peptidase |
2.05 Å |
3KEC |
3KEC |
3KEC |
3KEC |
3KEC |
3KEC |
Schnute et al., 2010 |
mature peptidase |
2.30 Å |
3KEJ |
3KEJ |
3KEJ |
3KEJ |
3KEJ |
3KEJ |
Schnute et al., 2010 |
mature peptidase |
1.97 Å |
3KEK |
3KEK |
3KEK |
3KEK |
3KEK |
3KEK |
Schnute et al., 2010 |
mature peptidase |
1.90 Å |
3KRY |
3KRY |
3KRY |
3KRY |
3KRY |
3KRY |
Becker et al., 2010 |
mature peptidase |
2.00 Å |
3LJZ |
3LJZ |
3LJZ |
3LJZ |
3LJZ |
3LJZ |
Shieh et al., 2011 |
mature peptidase |
1.90 Å |
3O2X |
3O2X |
3O2X |
3O2X |
3O2X |
3O2X |
|
mature peptidase |
2.43 Å |
3TVC |
3TVC |
3TVC |
3TVC |
3TVC |
3TVC |
Devel et al., 2012 |
mature peptidase |
1.98 Å |
3WV1 |
3WV1 |
3WV1 |
3WV1 |
3WV1 |
3WV1 |
Nara et al., 2014 |
mature peptidase |
2.30 Å |
3WV2 |
3WV2 |
3WV2 |
3WV2 |
3WV2 |
3WV2 |
Nara et al., 2014 |
mature peptidase |
1.60 Å |
3WV3 |
3WV3 |
3WV3 |
3WV3 |
3WV3 |
3WV3 |
Nara et al., 2014 |
mature peptidase |
1.30 Å |
3ZXH |
3ZXH |
3ZXH |
3ZXH |
3ZXH |
3ZXH |
Tommasi et al., 2011 |
catalytic domain; complex with 2-4-[4-(4-chloro-phenoxy)-benzenesulfonyl]-tetrahydro-pyran-4-yl-N-hydroxy-acetamide |
2.40 Å |
456C |
456C |
456C |
456C |
456C |
456C |
Lovejoy et al., 1999 |
mature peptidase |
2.20 Å |
4A7B |
4A7B |
4A7B |
4A7B |
4A7B |
4A7B |
De et al., 2012 |
mature peptidase |
2.85 Å |
4FU4 |
4FU4 |
4FU4 |
4FU4 |
4FU4 |
4FU4 |
Stura et al., 2013 |
mature peptidase |
2.44 Å |
4FVL |
4FVL |
4FVL |
4FVL |
4FVL |
4FVL |
Stura et al., 2013 |
mature peptidase |
2.54 Å |
4G0D |
4G0D |
4G0D |
4G0D |
4G0D |
4G0D |
Stura et al., 2013 |
mature peptidase |
1.43 Å |
4JP4 |
4JP4 |
4JP4 |
4JP4 |
4JP4 |
4JP4 |
De Savi et al., 2013 |
mature peptidase |
2.00 Å |
4JPA |
4JPA |
4JPA |
4JPA |
4JPA |
4JPA |
De Savi et al., 2013 |
mature peptidase |
1.66 Å |
4L19 |
4L19 |
4L19 |
4L19 |
4L19 |
4L19 |
Spicer et al., 2014 |
catalytic domain; complex with n- phenyl-4-((4h-1,2,4-triazol-3-ylsulfanyl)methyl)-1,3-thiazol-2-amine |
1.20 Å |
5B5O |
5B5O |
5B5O |
5B5O |
5B5O |
5B5O |
|
catalytic domain; complex with 4- oxo-n-(3-(2-(1h-1,2,4-triazol-3-ylsulfanyl)ethoxy)benzyl)-3,4- dihydroquinazoline-2-carboxamide |
1.60 Å |
5B5P |
5B5P |
5B5P |
5B5P |
5B5P |
5B5P |
|
mature peptidase |
1.85 Å |
5BOT |
5BOT |
5BOT |
5BOT |
5BOT |
5BOT |
Taylor et al., 2011 |
mature peptidase |
2.03 Å |
5BOY |
5BOY |
5BOY |
5BOY |
5BOY |
5BOY |
Taylor et al., 2011 |
mature peptidase |
1.79 Å |
5BPA |
5BPA |
5BPA |
5BPA |
5BPA |
5BPA |
Taylor et al., 2011 |
complex with selective inhibitor compound (s)-10a |
1.60 Å |
5UWK |
5UWK |
5UWK |
5UWK |
5UWK |
5UWK |
|
complex with selective inhibitor compound (s)-17a |
2.55 Å |
5UWL |
5UWL |
5UWL |
5UWL |
5UWL |
5UWL |
|
complex with selective inhibitor compound (r)-17a |
1.62 Å |
5UWM |
5UWM |
5UWM |
5UWM |
5UWM |
5UWM |
|
complex with selective inhibitor compound 10d |
3.20 Å |
5UWN |
5UWN |
5UWN |
5UWN |
5UWN |
5UWN |
|
complex with the peptide imisf |
1.71 Å |
6HV2 |
6HV2 |
6HV2 |
6HV2 |
6HV2 |
6HV2 |
|
catalytic domain; complex with 4-[4-(4-chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide |
1.60 Å |
830C |
830C |
830C |
830C |
830C |
830C |
Lovejoy et al., 1999 |
Mus musculus
|
catalytic domain |
2.00 Å |
1CXV |
1CXV |
1CXV |
1CXV |
1CXV |
1CXV |
Botos et al., 1999 |